CAB
is the abbreviation for combined androgen blockade and
is a type of prostate cancer hormone therapy which combines
an anti-androgen with either chemical castration or
surgical castration. 90 to 95 percent testosterone is
produced by the testicles while 5 to 10 percent is produced
by the adrenal glands. Combined androgen blockade ablates
100 percent of the testosterone present in the blood
stream. Combined androgen blockade is also known as
total androgen blockade and combined hormone blockade.
Keyword: prostate cancer hormone therapy, castration,
anti-androgen
|
